Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Ellen Barry
Author: Ellen Barry

Written by

Ellen Barry

in

Clinical Trials, Dopamine, Drugs (Pharmaceuticals), Food and Drug Administration, Karuna Therapeutics Inc, Psychiatry and Psychiatrists, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Schizophrenia, Therapy and Rehabilitation
←Museum at FIT Tells the Story of the African Diaspora Through Its Fashions
Inside the U.N. Dinner Party at Eleven Madison Park→

More posts

  • UK economy will grow by less than expected next year, OECD says

  • MIP London Comes To An End After Two Years; Organizers Launching New Event Alongside London Book Fair

  • UK to review Chagos Islands deal after Trump’s latest criticism

  • Dolly Parton Only Wanted Longtime Wig and Makeup Artist at Her Side When She Died

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube